Aguilar Laura K.'s Form 4 filing
Candel Therapeutics, Inc. (CADL) · filed Oct 15, 2024
- Accession no.
- 0001873919-24-000002
- Filed
- Oct 15, 2024, 5:59 PM ET
- Trade date
- Oct 11-15, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $243.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Aguilar Laura K.CIK 0001873915 | 10% Owner |
| Aguilar-Cordova EstuardoCIK 0001873919 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 11, 2024 | CADL | SSaleDisposed | −15,000 | $6.05 | −$90,750 | 944,873 | Direct | |
| Oct 14, 2024 | CADL | SSaleDisposed | −15,000 | $6.02 | −$90,300 | 929,873 | Direct | |
| Oct 15, 2024 | CADL | SSaleDisposed | −10,412 | $6.03 | −$62,784.36 | 919,461 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.